|
MAIN SUMMT - TUESDAY, FEBRUARY 26, 2008 |
7:30 am Continental Breakfast and Registration
8:00 am Chairman’s Welcome
Mike Leonetti, Executive Director, Healthcare Partnerships, Boehringer Ingelheim Pharmaceuticals, Inc., Chairman, ASAP Global Board of Directors
8:05 am Opening Address – From Radical Innovation to Radical Collaboration; The IT Industry in Flux
Bernard Meyerson, IBM Fellow, Vice President Strategic Alliances & CTO - IBM Systems & Technology Group
Semiconductor technology is no longer proceeding down the path of the prior 40 years, the ability to benefit from further scaling alone having been lost. This discontinuity led segments of the industry over a “power cliff” many did not see coming, driving the need for dramatic strategic and organizational shifts. Forced to move to a strategy demanding continuous innovation as the alternative to ongoing scaling, industry R&D expenditures grew at rates rendering prior business models and alignments financially unsustainable. This chain of events has led to a consolidation of competitors around global innovation networks engaged in pre-competitive alliances, and the emergence of a model based upon co-opetition as a business imperative as opposed to an option. Through alliances based upon the integration of both physical and intellectual capital, companies once again have achieved the critical mass required for financial stability.
Similarly, new technical models based upon Holistic Design, a system based view of technology’s future, has displaced semiconductor technology as the key differentiator in the global IT arena. This talk explores the implications these changes have for both industry and society at large and on the increased use of alliances and open system innovation as means to deal with these changes.
8:50 am Keynote Address - The Shift to an Alliance-Centric Business Model at Eli Lilly and Company
Gino Santini, Senior Vice President, Eli Lilly and Company
Eli Lilly and Company has shifted it’s corporate strategy from a “FIPCO” (Fully Integrated Pharmaceutical Company) model to a “FIPNET” (Fully Integrated Pharmaceutical Network) model. This evolution impacts every part of the value chain, (Research and Development, Manufacturing, and Sales and Marketing) and involves the extensive use of traditional partnering and outsourcing arrangements, as well as several new and innovative ones. This strategy requires significant internal governance and cultural changes, along with the acquisition of new capabilities. This presentation will examine the strategic drivers and the execution challenges of this process.
9:40 am Networking Break with Exhibit Viewing and One-to-One Meetings
10:20 am Creating New Value Streams through Corporate Alliances at Disney
Lawrence Aldridge, Senior Vice President, Corporate Alliances, The Walt Disney Company
In a cluttered global media landscape, Disney is
one of the few widely recognized and trusted brands. Through its
movies, parks and resorts, television networks and merchandising,
Disney reaches millions of families around the world, developing a
special bond through timeless storytelling and great characters. The
consistency of Disney’s strategic focus and the way the company
builds and manages its high-quality creative franchises across
multiple platforms and markets offers tremendous opportunity to the
companies it teams up with. With moms and kids playing an
ever-increasing role in family purchasing decisions
the world over, Disney and its partners are in a unique position to
influence them.
11:10 am Beyond Processes and People: Managing Global Alliance Complexities - Globalization, Co-Opetition and Portfolio Management
Greg Prynn, Senior Director, Strategic Alliances, Cisco Systems
This session will focus on three critical aspects of alliance management success: Portfolio Management; Managing Rival Partners – i.e. Co-opetition; and Globalization, the driving forces behind it and why organizations must partner globally. Portfolio Management - Most companies are still doing one-off alliances and wonder why their strategy fails. |
I. Portfolio Management and how to think differently about it.
- Why is portfolio management important for a Strategic Alliance program
- Creating a Portfolio Management System
- Brief Case Study: Unified Communications
|
II. Managing Rival Partners: Co-opetition
- Why some companies are partnering with more competitors than ever before
- How Cisco manages co-opetition
- Exit Strategies
III. Globalization: Reasons why you must partner globally
- Think differently: The world is more complex, intertwined, faster moving. You have to be connected globally or risk falling behind.
- Brief Case Study: Fujitsu
|
|
|
| 11:50 pm Luncheon |
Sponsored
by:

|
|
|
|
TUESDAY, FEBRUARY 26, 2008 -AFTERNOON |
|
TRACK 1 - BIOPHARMA COUNCIL TRACK |
TRACK 2 – IT/COMMUNICATIONS COUNCIL TRACK |
1:00 pm ASAP BioPharma Council Meeting
Chair: Mike Leonetti, Chairman, ASAP, Executive Director, Healthcare Partnerships, Boehringer Ingelheim Pharmaceuticals, Inc.
2:00 pm The Marriage of the Mind – Making Biopharmaceutical Collaboration Work
Salima Lin, Industry Leader, Component Business Model for Life Sciences, IBM Institute
Our research shows that collaboration is a key element of innovation. Yet, in a survey jointly conducted by IBM Institute for Business Value and Silico Research, more than half of all biopharmaceutical alliances did not work. Three traits are required for a successful alliance: internal alignment of the strategies, structures and scientific goals of the partners; properly managed boundaries; and lasting commitment. New tools and technologies can also play a major role in helping people within the extended enterprise communicate across time and space.
Collaboration is difficult – as the failure of so many biopartnering arrangements demonstrates. But most senior executives now recognize its importance in generating new ideas; they understand that there is no such thing as a monopoly when it comes to innovation. Unlocking this intellectual capital requires that a company align its strategy and structure with its scientific goals, learn how to manage internal and external boundaries, and remain committed to the shared enterprise. Enabling tools and technologies are also crucial for enabling all the participants to communicate and collaborate, unimpeded by distance.
2:40 pm The Enablex Alliance: An Opportunity to Leverage Best Practices
Simon Bateman, Global Business Development & Licensing, Novartis Pharmaceuticals Corporation
Laurie Streitmatter, Alliance Management and Health Care Human Resources, Procter & Gamble
This presentation is a case study of the US Enablex Alliance between Novartis and Procter & Gamble. The presentation discusses the unique aspects of the alliance and highlights the evolving best practices that enable the alliance to capture the value and capabilities of both partners. Key issues covered include:
- Outline of the Players, the Product (a prescription medicine to treat the symptoms of Overactive Bladder), and Creating the Deal
- The Challenges of Making the Deal Work, including each partner’s philosophy on alliances and Nine Key Elements for Success
- Capturing innovation and best practices from Novartis and P&G, including Issues of Tracking, Culture Assessments, and Health Checks
|
1:00 pm
Driving Effective Marketing with Channel & Alliances
Toni Adams, Senior
Director of Global Partner and Channel Marketing, Symantec
Corporation
Channel and Alliances marketing are typically seen as
separate disciplines in the way that vendors handle the
account management the Marketing, the go-to-market as well as
of these partner types. Through real-world examples, find out
how the Channel can be cross-leveraged in driving effective
Alliances marketing activities and vica versa. In addition
this talk looks to guide you on the topic of setting up the
right team to enable you to do effective Marketing with
Channel & Alliances.
1:40 pm Technology for Collaboration - A Joint Presentation:
Technology for Alliance Management – Findings from the Gartner-ASAP Survey
Carol Rozwell, Vice President and Distinguished Analyst, Gartner
Alliances are the way business gets done today. But despite their importance, few organizations exploit technology to support alliance development and management. This presentation will explore some interesting findings from the Gartner-ASAP survey.
Alliances 2.0: Channels of the Future: Using Next Generation Internet Tools To Manage Partnerships
Steve Maul, Executive Vice President, Chief Learning and Strategy Officer, InfoMentis
This session will provide you with some of the latest insights into how you can improve the performance of your channel operations by:
- Understanding the communication shift and what your company should be doing to protect its interests
- Taking advantage of new opportunities with small customers who are more comfortable with buying online than dealing with live people
- Meeting the changing needs of your reseller sales people before your competition
2:20 pm Alliance Partners, Competitors, or Both? – Keys to Successfully Managing Co-opetition
Pat Campbell, HP Worldwide Manager Infrastructure Alliances, Hewlett-Packard Company
Steve Barriero, CA, Director, Strategic Global Alliances
As alliance efforts become more common and companies are increasing their efforts to form industry alliances, it is also becoming more common to form relationships with competitors. This session will identify the challenges of common competitive issues and the creative ways HP and CA have found to cooperate and avoid clashing in order to drive revenue with a common install base of customers. Key issues to be covered:
- Product Development - collaboration between competing products at the Product
Management Level
- Customer Support - avoiding the finger pointing to resolve customer issues
- Supporting the Sales Process
- Alliance Process Improvement – Changing and improving how we partner
|
| 3:20 pm Networking Break with Exhibit Viewing and One-to-One Meetings |
3:00 pm Networking Break with Exhibit Viewing and One-to-One Meetings |
4:00 pm
The Power of Alliances: The Physics of Business Transformation
Lilia Kiselev, Director, Alliance Management, Abbott
Edward J. Zajac, James F. Beré Professor of Management and Organizations, Kellogg School of Management
Leo Adalbert, Alliance and Program Director, Business Development, AstraZeneca
The Abbott and AstraZeneca collaboration involves the co-development and commercialization of CRESTOR® and Next-Generation TriCor® (ABT-335) fixed-dose combination therapy. This presentation highlights our approach in building and sustaining a high performance team that leverages points of difference and non-conventional approaches to maximizing long-term value creation.
4:40 pm
The Project Management – Alliance Management Interface Presentations and Panel Discussion
Moderator: Errol Jones, Manager, Project Planning and Execution, Integrated Project Management Co., Inc.
Panelists: Jeremy Ahouse, Senior Manager, Alliance Management, Immunogen
Ratnakar Mitra, Vice President, Alliance Management, Schering Plough
Kimberly Brue, Alliance Director, sanofi pasteur
We explore the alliance executive’s perspective in managing the interface between alliance management and project management. Topics addressed include:
- How can Alliance managers and Project leaders Maximize their effectiveness (together)
- Traps, Issues and Learnings: Why Alliance management will never replace the need for Project managers
- The role of Alliance Management, comparisons and contrasts with Project management
- Ensuring proper coordination and hand-offs between Alliance management and Project management
Additional Panelists, TBA |
3:30 pm Developing Global Vertical Go-to-Market Programs with System Integrator Partners
Tyler Prince, Group Vice President, North America Alliances and Channels, Oracle
As one of the world’s largest enterprise software companies, Oracle has successfully transformed itself into an industry-oriented, solution based company. This session will focus on how Oracle has also transformed its strategic alliance program to support an industry go-to-market approach with the Global System Integrators. Key areas include:
- Business justification for developing Vertical GTM Program with Global SI’s
- Challenges in aligning a new program with Global SI’s
- Measurements and metrics required to drive success of these GTM programs
4:10 pm Converting to a Fee Based Partner Program
Larry W. Acord, Director Business Development, CA
This session will discuss redesigning a partner program within a large company and making it self funding. The session will discuss changes in roles within the company and increasing partner participation through increased interactions with the partners. This session will provide a blueprint for companies looking to redesign & re-launch their partner programs. Key topics to be covered include:
- Selling a “Self-Funding Partner Program” within your company and to existing partners
- Establishing an off-shore office: Do’s & Don’ts
- Reporting vehicles and SOP’s to support “Self-Funding Partner Programs”·
- Extending the footprint of the program internationally
4:50 pm Alliance Management Practices Needed to Succeed in Channel
Relationships
Brian Boekel, Partner Manager, Agilysys, Inc
Developing successful channel programs are an important aspect of building a successful Technology company. Developing a successful Solution Provider / VAR requires the selection & management of the right partners. Alliance Management in both organizations can make these relationships more successful. Learn from front line implementations and Best Practices on managing these Go-To-Market Alliances. |
| 5:20 pm End of Day One Sessions |
5:30 pm End of Day One Sessions |
6:30 pm Cocktail Reception (Sponsorship Opportunities Available. Contact Arnie Wolfson at
awolfson@healthtech.com or 781-972-5431.)
|